Specialist Updates 
COVID-19
Rheumatology

EU evaluating arthritis drug to treat COVID-19

The interleukin-1 receptor antagonist may reduce cytokine storm, according to the European Medicines Agency
Reuters Health
0
29 July 2021
Save
ClosePlease login

Europe’s medicines regulator is evaluating an application to use anakinra to treat COVID-19 in adults with pneumonia who are at risk of severe respiratory failure, the agency has announced.

Anakinra is the latest potential COVID-19 treatment to be reviewed by the European Medicines Agency (EMA) as the more infectious Delta variant of the coronavirus spurs an increase in cases.

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Content that breaches the privacy of other individuals
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .